Brief: Synact Pharma Q4 Operating Expenses Up At SEK 91.1 Mln

SynAct Pharma AB

23/02/2024 06:44

Feb 23 (Reuters) - SynAct Pharma AB  SYNACT.ST :
    * Q4 OPERATING EXPENSES AMOUNTED TO SEK 91,062 (30,523)
THOUSAND
    * Q4 GROUP’S LOSS AFTER TAX AMOUNTED TO SEK 90,543 (30,477)
THOUSAND

Source text for Eikon:  ID:nMFN3nfz2p 
Further company coverage:  SYNACT.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))